Alkeus Pharmaceuticalsincis A Biopharmaceutical Company Based In Cambridgemassachusettsfocused On Developing Therapies For Severe Retinal Diseasesfounded In 2010 By Leonide Saadph D And Ilyas Washingtonph D The Company Aims To Address High Unmet Medical Needsparticularly For Conditions Like Stargardt Disease And Geographic Atrophy Secondary To Age Related Macular Degeneration The Company S Lead Productgildeuretinol Acetatealk 001 Is An Oral Small Molecule Drug Designed To Reduce Toxic Vitamin A Dimerization In The Retinaclinical Trials Have Shown Its Potential To Slow Lesion Growth In Stargardt Patients And Improve Visual Acuity In Geographic Atrophy Patientsalkeus Is Actively Conducting Clinical Programsincluding The Tease Studies For Stargardt Disease And The Saga Study For Geographic Atrophydemonstrating Significant Progress In Treating These Conditionsthe Company Has Received Multiple Fda Designationsincluding Breakthrough Therapy And Orphan Drug Statushighlighting Its Commitment To Advancing Therapies For Patients Facing Progressive Vision Loss
No conferences found for this company.
| Company Name | Alke Research Pvt Ltd |
| Country |
India
|
| Address | N/A |
| Telephone | N/A |
| N/A |
